Deep remission from induction chemotherapy predicts favorable long-term survivals in early stage extranodal nasal NK/T-cell lymphoma receiving sequential chemotherapy and radiation

Fei Qi; Wenyuan Zhou; Yan Xie; Yan Sun; Meng Wu; Yue Chai; Bo Chen; Ningjing Lin; Weiping Liu; Ning Ding; Yexiong Li; Mei Dong; Yuqin Song; Jun Zhu

doi:doi:10.18632/aging.204355

← Back

Research Paper Volume 14, Issue 21 pp 8729—8744

Deep remission from induction chemotherapy predicts favorable long-term survivals in early stage extranodal nasal NK/T-cell lymphoma receiving sequential chemotherapy and radiation

Figure 3. Comparisons of survivals between early stage NKTCL patients with different induction chemotherapy responses. Survival cures for entire patients in the primary cohort (A and B) and the validation cohort (C and D); survival cures for patients with final CR in the primary cohort (E and F) and the validation cohort (G and H). Abbreviations: PFS: progression-free survival; OS: overall survival; CR: complete remission; PR: partial remission; NR: non-response.